Overview
Chongyu Su practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Lung Cancer, and Squamous Cell Lung Carcinoma.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chongyu Su
Is Chongyu Su a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Chongyu Su is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chongyu Su participate in research or clinical trials?
Yes. Chongyu Su has published 15 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Chongyu Su's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaSu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerSu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Squamous Cell Lung Carcinoma